Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05107479 · ClinicalTrials.gov registry record · NA

Effectiveness of Interactive Voice Response for COVID-19 Vaccination Training in the Democratic Republic of the Congo

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
8,959
Enrollment target

NCT05107479: Completed NA study, sponsored by Stanford University.

NCT05107479 is a NA study that has completed, run by Stanford University. The registered enrollment target is 8,959 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05107479, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
8,959 participants
Enrollment target

Study Summary

This study seeks to evaluate the effectiveness of a remote training course delivered via interactive voice response (IVR) to the mobile phones of frontline providers in the Democratic Republic of the Congo (DRC) during the COVID-19 pandemic. The randomized trial will examine the impact of the training on health workers' knowledge, beliefs and intended behaviors related to COVID-19 vaccines and vaccine administration. Potential enrollees will be consented first, after which the participants assigned to the treatment group will be invited to participate in the training over a one month period, while the control group will receive the intervention following a month delay, which will allow for the comparison of knowledge and beliefs with a group that is controlled for bias introduced by time. We hypothesize that the training will lead to increased knowledge about vaccines, lower vaccine hesitancy, and increased preparedness to administer vaccines among trained health workers.

Interventions

  • BEHAVIORAL Control Condition
  • BEHAVIORAL COVID-19 Vaccine IVR Training

Trial Details

FieldValue
Enrollment Target 8,959 participants
Start Date 2021-11-09
Est. Completion 2022-02-10
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT05107479

The ClinicalTrials.gov registry entry for NCT05107479 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8,959 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Control Condition is the first listed.

NCT05107479 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05107479 about?

NCT05107479 is a clinical study titled "Effectiveness of Interactive Voice Response for COVID-19 Vaccination Training in the Democratic Republic of the Congo". This study seeks to evaluate the effectiveness of a remote training course delivered via interactive voice response (IVR) to the mobile phones of frontline providers in the Democratic Republic of the Congo (DRC) during the COVID-19 pandemic. The randomized trial will examine the impact of the traini...

What is the current status of trial NCT05107479?

This trial is currently completed. It is a NA study. The enrollment target is 8,959 participants. The study started on 2021-11-09. Estimated completion is 2022-02-10.

What interventions are being tested in trial NCT05107479?

The interventions under investigation include: Control Condition (BEHAVIORAL), COVID-19 Vaccine IVR Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT05107479?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.